{"gene":"KCNJ8","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1997,"finding":"Kir6.1 (KCNJ8) coexpressed with SUR2B forms a ~33 pS K+ channel that is activated by K+ channel openers (pinacidil, nicorandil) and nucleotide diphosphates (UDP, GDP), inhibited by glibenclamide, but not inhibited by intracellular ATP alone—defining it as an NDP-dependent rather than classical ATP-sensitive K+ channel.","method":"Patch-clamp electrophysiology (cell-attached and inside-out configurations) in HEK293T cells co-expressing SUR2B and Kir6.1","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in heterologous system with multiple patch-clamp configurations, foundational paper with 328 citations","pmids":["9130167"],"is_preprint":false},{"year":1996,"finding":"SUR1 is required to confer diazoxide sensitivity and ATP sensitivity on Kir6.1; Kir6.1 alone expressed in HEK293 cells is unaffected by diazoxide or ATP dialysis, but Kir6.1+SUR1 co-expression restores both diazoxide activation and ATP inhibition.","method":"Whole-cell patch-clamp in HEK293 cells transiently transfected with Kir6.1 alone or Kir6.1+SUR1","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — direct electrophysiological reconstitution comparing subunit combinations","pmids":["8865068"],"is_preprint":false},{"year":2002,"finding":"Genetic knockout of Kir6.1 (Kcnj8) in mice abolishes K+ channel opener (pinacidil)-induced currents in vascular smooth muscle cells and eliminates vasodilation responses to pinacidil, demonstrating that Kir6.1 is the pore-forming subunit of the vascular smooth muscle KATP channel required for normal coronary artery tone regulation.","method":"Kir6.1 knockout mouse model; patch-clamp of vascular smooth muscle cells; pharmacological challenge with pinacidil and methylergometrine","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and physiological phenotype, 284 citations, replicated by multiple downstream studies","pmids":["11984590"],"is_preprint":false},{"year":1997,"finding":"Kir6.1 protein localizes predominantly to mitochondria in rat skeletal muscle, cardiac muscle, liver, and pancreas, as demonstrated by immunoblot of mitochondrial fractions and electron-microscopic immunogold labeling of the inner mitochondrial membrane, suggesting a role as a subunit of mitochondrial KATP channels.","method":"Subcellular fractionation + immunoblot; immunofluorescence; immunoelectron microscopy with colloidal gold","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 localization — multiple orthogonal methods, but later work (PMID:18068667) questioned antibody specificity for mitochondrial assignment","pmids":["9434770"],"is_preprint":false},{"year":2001,"finding":"In the rat brain, Kir6.1 is the principal pore-forming subunit of plasma membrane KATP channels specifically in astrocytes (hippocampal, cortical, cerebellar), localized to perisynaptic and peridendritic astrocyte processes, with functional KATP channels confirmed in Bergmann glia by slice-patch-clamp.","method":"Immunohistochemistry with subunit-specific antibodies; ultrastructural immunolocalization; slice-patch-clamp electrophysiology","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (immunohistochemistry, ultrastructure, electrophysiology), 105 citations","pmids":["11749042"],"is_preprint":false},{"year":2004,"finding":"Native KATP channels in primary human coronary artery endothelial cells (HCAEC) are heteromultimeric complexes of Kir6.1, Kir6.2, and SUR2B subunits, demonstrated by reciprocal co-immunoprecipitation and co-localization by confocal microscopy at the cell surface.","method":"Reciprocal co-immunoprecipitation; Western blotting; confocal microscopy; RT-PCR","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus co-localization, demonstrating native heteromultimeric complex","pmids":["15380676"],"is_preprint":false},{"year":2010,"finding":"The KCNJ8-S422L missense mutation causes a marked gain-of-function in cardiac KATP current (Kir6.1/SUR2A), with significantly increased current over 0–40 mV range, identifying reduced ATP sensitivity as the mechanistic basis for J-wave syndrome susceptibility.","method":"Site-directed mutagenesis; whole-cell patch-clamp of COS-1 cells co-expressing Kir6.1-S422L and SUR2A","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis with functional electrophysiological characterization, replicated in independent lab (PMID:22056721)","pmids":["20558321"],"is_preprint":false},{"year":2011,"finding":"The KCNJ8-S422L gain-of-function is mechanistically explained by reduced sensitivity to intracellular ATP inhibition (IC50 shifted from 38.4 μM for WT to 785.5 μM for mutant), leading to incomplete channel closure under normoxic conditions; whole-cell current is increased ~2-fold when co-expressed with SUR2A-WT.","method":"Whole-cell and inside-out patch-clamp in TSA201 cells; direct DNA sequencing of probands","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 1 — in vitro electrophysiology with quantified ATP IC50 shift, independent replication of S422L gain-of-function","pmids":["22056721"],"is_preprint":false},{"year":2014,"finding":"De novo Kir6.1[C176S] (KCNJ8) mutation causes Cantú syndrome through a gain-of-function mechanism: markedly higher channel activity due to reduced ATP sensitivity, whether co-expressed with SUR1 or SUR2A, establishing that Cantú syndrome results from gain of KATP channel function.","method":"Heterologous expression; patch-clamp electrophysiology; genetic sequencing of ABCC9-negative Cantú syndrome patient","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1-2 — functional characterization with two SUR partners plus clinical genetics, mechanistically definitive","pmids":["24700710"],"is_preprint":false},{"year":2002,"finding":"Protein kinase C (PKC) inhibits Kir6.1/SUR2B channel activity but enhances Kir6.2/SUR2B activity; purified PKC directly inhibits Kir6.1/SUR2B in inside-out patches with NDP, and this inhibition is blocked by a specific PKC inhibitor peptide, establishing PKC as a regulator that discriminates between the two Kir6.x channel types.","method":"Inside-out patch-clamp; application of purified PKC catalytic fragment; phorbol ester activation; specific PKC inhibitor peptide","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical reconstitution with purified kinase plus electrophysiology, rigorous controls","pmids":["12015420"],"is_preprint":false},{"year":2007,"finding":"PKC inhibition of the vascular Kir6.1/SUR2B channel is mediated by a motif of four phosphorylation repeats (Ser-354, Ser-379, Ser-385, Ser-391, Ser-397) in the distal C-terminus of Kir6.1; combined mutation of these five serines to alanine almost completely abolishes PKC-dependent channel inhibition and reduces in vitro 32P incorporation.","method":"Kir6.1-Kir6.2 chimeras; site-directed mutagenesis; whole-cell patch-clamp in HEK293 cells; in vitro 32P phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis + in vitro phosphorylation assay + electrophysiology, identifies specific phosphorylation sites","pmids":["18048350"],"is_preprint":false},{"year":2007,"finding":"Arginine vasopressin (AVP) inhibits Kir6.1/SUR2B channel activity via Gq-coupled V1a receptor and PKC signaling; AVP suppresses channel open-state probability without altering single-channel conductance, and the effect is blocked by selective PKC inhibitors.","method":"Whole-cell patch-clamp in HEK293 cells co-expressing Kir6.1/SUR2B with V1a receptor; isolated mesenteric artery ring tension studies","journal":"American journal of physiology. Regulatory, integrative and comparative physiology","confidence":"High","confidence_rationale":"Tier 1-2 — electrophysiology plus vascular pharmacology with receptor and kinase pathway identification","pmids":["17428891"],"is_preprint":false},{"year":1999,"finding":"Co-expression of Kir6.1 with SUR2B increases the affinity of SUR2B for glibenclamide ~5-fold (Kd from 32 nM to 6 nM), establishing that the pore-forming Kir6.1 subunit modulates pharmacological properties of the SUR2B regulatory subunit.","method":"Radioligand binding assays; whole-cell voltage-clamp in transfected HEK cells","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 — quantitative binding assay plus electrophysiology in defined reconstituted system","pmids":["10531400"],"is_preprint":false},{"year":2006,"finding":"KCNJ8 (Kir6.1) knockout mice show fatal susceptibility to endotoxemia linked to loss of coronary vasodilation capacity; K+ channel opener drug improved survival in WT but not Kir6.1 KO, placing Kir6.1 as the essential vascular sensor coupling metabolic demand to coronary vasoreactivity during septic shock.","method":"Kcnj8 KO mouse model; LPS-induced endotoxemia challenge; pharmacological rescue with K+ channel opener","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cardiovascular phenotype and pharmacological rescue experiment","pmids":["17077304"],"is_preprint":false},{"year":2013,"finding":"Smooth muscle-specific expression of ATP-insensitive Kir6.1[G343D] gain-of-function transgene reduces systolic and diastolic blood pressure and blunts mesenteric artery contractile responses; dominant-negative Kir6.1 in smooth muscle elevates blood pressure, directly demonstrating that Kir6.1 overactivity in vascular smooth muscle causes chronic hypotension.","method":"Conditional transgenic mouse model (tamoxifen-inducible smooth muscle Cre); blood pressure telemetry; isolated vessel contractility; patch-clamp of mesenteric myocytes","journal":"Journal of the American Heart Association","confidence":"High","confidence_rationale":"Tier 2 — conditional transgenic gain- and loss-of-function with multiple phenotypic readouts","pmids":["23974906"],"is_preprint":false},{"year":2008,"finding":"The metabolic sensitivity of Kir6.1/SUR2B channels is intrinsic and independent of PKA regulation; unlike Kir6.2-containing channels where ATP sensitivity resides in the pore subunit, metabolic sensitivity of Kir6.1/SUR2B is a property of the SUR2B subunit's nucleotide-binding domains (both NBDs required).","method":"86Rb efflux assay; patch-clamp in HEK293 and CHO cells; site-directed mutagenesis of SUR2B NBDs","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of NBDs combined with functional assays identifies mechanistic distinction","pmids":["18522960"],"is_preprint":false},{"year":2011,"finding":"Loss-of-function KCNJ8 mutations (E332del and V346I) reduce pinacidil-activated KATP current by 40–68% when co-expressed with SUR2A, identifying reduced channel function as a novel pathogenic mechanism in SIDS.","method":"Whole-cell patch-clamp in COS-1 cells; site-directed mutagenesis; DNA sequencing of SIDS cohort","journal":"Circulation. Cardiovascular genetics","confidence":"High","confidence_rationale":"Tier 1 — functional electrophysiology of two independent mutations with quantified loss-of-function","pmids":["21836131"],"is_preprint":false},{"year":2017,"finding":"Cantú syndrome-associated Kir6.1-V65M mutation in the slide helix increases open state stability and markedly reduces ATP sensitivity and high-affinity glibenclamide sensitivity in both intact cells and excised patches; this effect is subunit-specific (methionine but not leucine substitution causes the effect) and is conserved at the equivalent position in Kir6.2.","method":"Ion flux assay (86Rb efflux); patch-clamp in intact and excised configurations; site-directed mutagenesis of V65M and V65L in Kir6.1, V64M and V64L in Kir6.2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with multiple orthogonal functional assays, mechanistically defines slide helix role","pmids":["28842488"],"is_preprint":false},{"year":2000,"finding":"Dominant-negative Kir6.1 suppresses SUR2B+Kir6.1 currents but has no effect on native KATP currents in adult rabbit ventricular myocytes, while dominant-negative Kir6.2 does suppress ventricular KATP current, demonstrating that Kir6.1 and Kir6.2 do not functionally heteromultimerize and that Kir6.2 is the sole KATP pore-forming subunit in ventricular cardiomyocyte surface membranes.","method":"Adenoviral gene transfer of dominant-negative constructs; whole-cell patch-clamp in A549 cells and native rabbit ventricular myocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — dominant-negative approach in native cells with rigorous controls, directly tests heteromultimerization","pmids":["10837494"],"is_preprint":false},{"year":2010,"finding":"Heterologously expressed Kir6.1-GFP and endogenous Kir6.1 localize predominantly to the endoplasmic reticulum rather than mitochondria or plasma membrane; dominant-negative Kir6.1 constructs significantly reduce ATP-stimulated Ca2+ transient amplitude in C2C12 muscle cells, suggesting Kir6.1 modifies Ca2+ release from the ER.","method":"Live cell imaging of Kir6.1-GFP; subcellular fractionation; siRNA knockdown and dominant-negative expression; Ca2+ imaging with fluorescent indicators","journal":"The Journal of membrane biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods but single lab; challenges prior mitochondrial localization claims","pmids":["20306027"],"is_preprint":false},{"year":2007,"finding":"Functional Kir6.1/SUR1 channels are located at excitatory pre-synaptic terminals in the hippocampus; genetic deletion of Kir6.1 or SUR1 increases vulnerability to seizures and enhances glutamate release at CA3 synapses as measured by whole-cell patch-clamp recordings.","method":"Immunolocalization; Kir6.1/SUR1 knockout mice; whole-cell patch-clamp recordings from hippocampal slices; seizure susceptibility assay","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with direct electrophysiological readout of synaptic transmission and defined pathway placement","pmids":["17883401"],"is_preprint":false},{"year":2012,"finding":"Kir6.1 physically associates with Cx43 in a phospho-specific manner: Cx43 phosphorylated at serine 262 preferentially interacts with Kir6.1, and introduction of S262A phospho-deficient mutation completely abolishes the interaction.","method":"Pull-down assay; co-immunoprecipitation; co-localization studies; phospho-deficient mutagenesis","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with mutagenesis confirmation, single lab","pmids":["22960107"],"is_preprint":false},{"year":2014,"finding":"PKC epsilon mediates the interaction between Cx43 (phosphorylated at S262) and Kir6.1 in cardiomyocyte mitochondria; this interaction prevents mitochondria-mediated hypoxia-induced cell apoptosis.","method":"Co-immunoprecipitation in H9C2 cardiomyocytes; hypoxia treatment; PKCε-specific pathway manipulation; apoptosis assays","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with defined kinase and functional consequence, single lab","pmids":["24815185"],"is_preprint":false},{"year":2009,"finding":"LPS up-regulates Kir6.1 and SUR2B mRNA expression in vascular smooth muscle via NF-κB-dependent signaling, leading to augmented KATP channel activity and cell hyperpolarization; this effect is abolished by NF-κB inhibitors and does not occur in heterologous cells lacking the LPS signaling pathway.","method":"Quantitative PCR; patch-clamp of aortic smooth muscle cells; pharmacological NF-κB inhibition; isolated mesenteric artery ring assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods identifying transcriptional mechanism, pathway placement via NF-κB inhibitors","pmids":["19959479"],"is_preprint":false},{"year":2018,"finding":"Kir6.1 deficiency in microglia enhances p38 MAPK-NF-κB pathway activation and shifts microglia toward the M1 (pro-inflammatory) phenotype; suppression of p38 MAPK in vivo partially rescues the effects of Kir6.1 ablation on microglia polarization and dopaminergic neuron death.","method":"Kir6.1 knockdown/overexpression in microglia; Kir6.1 KO mouse PD model; p38 MAPK inhibitor in vivo; M1/M2 marker analysis","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — KO plus pharmacological rescue with defined signaling pathway, multiple readouts","pmids":["29540778"],"is_preprint":false},{"year":2019,"finding":"Astrocytic Kir6.1/KATP channel promotes mitophagy; its deletion inhibits mitophagy leading to accumulation of damaged mitochondria, increased ROS production, and neuroinflammation in astrocytes; restoration of mitophagy rescues the deleterious effects of astrocytic Kir6.1 KO on mitochondrial dysfunction and dopaminergic neuron death.","method":"Astrocyte-specific Kir6.1 KO mice; MPTP PD model; autophagy/mitophagy assays in vivo and in vitro; mitochondrial ROS measurements","journal":"Brain, behavior, and immunity","confidence":"High","confidence_rationale":"Tier 2 — cell-type specific KO with mechanistic rescue experiment identifying mitophagy pathway","pmids":["31288070"],"is_preprint":false},{"year":2019,"finding":"Kir6.1 physically associates with NLRP3 and inhibits NLRP3 inflammasome assembly; Kir6.1 depletion activates the NLRP3 inflammasome and worsens insulin resistance, while Kir6.1 overexpression has the opposite effect both in vivo and in vitro.","method":"Co-immunoprecipitation; Kir6.1 knockdown/overexpression in mice and primary cells; NLRP3 inflammasome assembly assays; insulin resistance measurements","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP plus gain/loss-of-function with functional consequence, single lab","pmids":["31387986"],"is_preprint":false},{"year":2022,"finding":"Astrocytic Kir6.1 deletion promotes astroglial NF-κB activation and extracellular release of complement C3, which interacts with neuronal C3aR to induce neuron death; NF-κB inhibition or C3aR antagonism rescues neuron death caused by astrocytic Kir6.1 KO.","method":"Astrocyte-specific Kir6.1 KO mice; LPS-induced PD model; NF-κB inhibitor and C3aR antagonist rescue experiments; C3 expression and secretion assays","journal":"Brain, behavior, and immunity","confidence":"High","confidence_rationale":"Tier 2 — cell-type specific KO with defined signaling axis (NF-κB→C3→C3aR) and pharmacological rescue","pmids":["33838249"],"is_preprint":false},{"year":2022,"finding":"Kir6.1 physically interacts with NLRP3 and prevents NLRP3 inflammasome assembly in astrocytes; astrocyte-specific Kir6.1 KO increases NLRP3-mediated pyroptosis in response to chronic stress, and NLRP3 inhibitor VX-765 rescues depressive-like behaviors in astrocytic Kir6.1 KO mice.","method":"Astrocyte-specific Kir6.1 KO mice; chronic stress depression models; Co-immunoprecipitation of Kir6.1 and NLRP3; pharmacological NLRP3 inhibition rescue","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP plus cell-type specific KO with behavioral rescue, single lab","pmids":["36185602"],"is_preprint":false},{"year":2022,"finding":"KCNJ8/ABCC9-containing KATP channel cell-autonomously regulates brain vascular smooth muscle cell (VSMC) differentiation through modulation of intracellular Ca2+ oscillations via voltage-dependent calcium channels; Kcnj8 KO mice show deficient VSMC differentiation and impaired neurovascular coupling.","method":"Kcnj8 KO mice; zebrafish KCNJ8/ABCC9 loss/gain-of-function; cell culture; Ca2+ imaging; live in vivo vascular imaging","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — multiple model systems (mouse, zebrafish, cell culture) with mechanistic Ca2+ pathway identification","pmids":["35588738"],"is_preprint":false},{"year":2020,"finding":"Kir6.1/SUR2B subunits underlie KATP channels in lymphatic smooth muscle; smooth muscle-specific Kir6.1 gain-of-function profoundly impairs lymphatic contractility and hyperpolarizes lymphatic smooth muscle, partially rescued by glibenclamide, explaining lymphoedema in Cantú syndrome.","method":"Kir6.1 KO and SUR2 KO mice; smooth muscle-specific Kir6.1 GoF mice; pressure myography; patch-clamp; electrophysiology of human LSM","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models with electrophysiology and pharmacological rescue, mechanistically links Kir6.1 GoF to lymphatic dysfunction","pmids":["32372450"],"is_preprint":false},{"year":2020,"finding":"Kir6.1/SUR2 subunits underlie intestinal smooth muscle KATP channels; Cantú syndrome knockin mice carrying KCNJ8 and ABCC9 mutations show severely reduced intestinal contractility and GI insufficiency rescued by glibenclamide.","method":"Cantú syndrome knockin mice; intestinal motility assays; glibenclamide pharmacological rescue","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 — human disease-relevant knockin mouse model with therapeutic rescue","pmids":["33170808"],"is_preprint":false},{"year":2016,"finding":"Gain-of-function Kir6.1 mutations expressed in pancreatic β cells under RIP control cause glucose intolerance and diabetes via reduced insulin secretion; BAC-Kir6.1[G343D] mice also show impaired glucose-stimulated insulin secretion, implicating native Kir6.1 in pancreatic KATP channel function.","method":"Transgenic mice (RIP-Cre and BAC-Kir6.1 GoF); glucose tolerance tests; insulin secretion assays; quantitative RT-PCR for native Kir6.1 in islets","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 2 — conditional transgenic GoF in specific cell type with defined secretory phenotype","pmids":["27956473"],"is_preprint":false},{"year":2020,"finding":"miR-223 is induced by methylglyoxal (MGO) in vascular smooth muscle cells and post-transcriptionally downregulates Kir6.1 mRNA via a 3'UTR binding site; miR-223 overexpression reduces Kir6.1 protein, inhibits KATP channel activity, and enhances vasoconstriction, while miR-223 knockdown attenuates MGO-induced Kir6.1 suppression.","method":"miR-223 overexpression/knockdown; luciferase reporter + 3'UTR mutagenesis; Western blot; patch-clamp; mesenteric artery ring assays","journal":"Vascular pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — luciferase reporter with mutagenesis confirms direct 3'UTR interaction, corroborated by electrophysiology and vascular function","pmids":["32151743"],"is_preprint":false},{"year":2017,"finding":"FoxO1 directly regulates Kir6.1 expression by binding to a functional FoxO1-binding site in the Kir6.1 promoter; FoxO1 activation downregulates Kir6.1 expression and decreases mitochondrial membrane potential, while FoxO1 inactivation upregulates Kir6.1.","method":"Chromatin immunoprecipitation (ChIP); Kir6.1 overexpression and cardiac-specific KO in DCM mice; Western blot for AKT/FoxO1 phosphorylation","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP assay identifies functional promoter binding site; AKT-FoxO1 pathway placed upstream of Kir6.1","pmids":["33547878"],"is_preprint":false},{"year":2024,"finding":"NK-cell specific Kcnj8 ablation results in fewer mature (CD27-CD11b+, KLRG1+) NK cells in bone marrow and spleen; patch-clamp shows a Kir6.1 blocker PNU-37883A-sensitive current in a subset of NK cells, establishing a role for Kir6.1-containing KATP channels in NK cell maturation.","method":"NK cell-specific Kir6.1 KO mice; patch-clamp of NK cells; flow cytometry; transcriptomics","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type specific KO with electrophysiological confirmation of channel current in NK cells","pmids":["39687626"],"is_preprint":false}],"current_model":"KCNJ8 encodes Kir6.1, an inwardly rectifying K+ channel subunit that assembles with sulfonylurea receptor subunits (primarily SUR2B in vascular smooth muscle, SUR1 in astrocytes and some neurons) to form KATP channels; these channels are not inhibited by ATP through the Kir6.1 pore but instead are gated by nucleotide diphosphates at SUR2B's NBDs, activated by K+ channel openers, and inhibited by glibenclamide and PKC (via four C-terminal phosphorylation repeats); gain-of-function mutations (S422L, C176S, V65M, A88G) reduce ATP sensitivity and increase channel open probability causing J-wave syndromes or Cantú syndrome, while loss-of-function causes Prinzmetal angina-like coronary vasospasm and increased endotoxemia susceptibility; beyond vascular tone, Kir6.1 also regulates astrocytic mitophagy and NLRP3 inflammasome assembly via direct physical interaction with NLRP3, brain VSMC differentiation through Ca2+ oscillation modulation, lymphatic and intestinal smooth muscle contractility, NK cell maturation, and pancreatic insulin secretion."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing that Kir6.1 requires a sulfonylurea receptor partner for pharmacological and ATP-gating properties resolved the question of whether Kir6.1 alone could form a functional KATP channel.","evidence":"Patch-clamp of HEK293 cells expressing Kir6.1 alone versus Kir6.1+SUR1 showed SUR1 confers diazoxide and ATP sensitivity","pmids":["8865068"],"confidence":"High","gaps":["Tissue-specific SUR partner preferences not yet defined","Single-channel properties of Kir6.1/SUR1 not characterized"]},{"year":1997,"claim":"Reconstitution of Kir6.1/SUR2B revealed a channel gated by nucleotide diphosphates rather than inhibited by ATP, distinguishing it fundamentally from the Kir6.2-based pancreatic KATP channel.","evidence":"Inside-out and cell-attached patch-clamp of HEK293T cells coexpressing Kir6.1 and SUR2B","pmids":["9130167"],"confidence":"High","gaps":["Structural basis for NDP activation at SUR2B unknown","In vivo identity of the Kir6.1/SUR2B channel not yet confirmed"]},{"year":1999,"claim":"Demonstration that Kir6.1 enhances SUR2B glibenclamide affinity ~5-fold established that the pore subunit allosterically modulates the pharmacology of its regulatory partner.","evidence":"Radioligand binding assays comparing SUR2B alone versus SUR2B+Kir6.1 in HEK cells","pmids":["10531400"],"confidence":"High","gaps":["Structural interface between Kir6.1 and SUR2B mediating allosteric coupling unresolved"]},{"year":2000,"claim":"Dominant-negative experiments in ventricular myocytes showed Kir6.1 and Kir6.2 do not heteromultimerize in the heart, clarifying tissue-specific subunit composition.","evidence":"Adenoviral dominant-negative Kir6.1 and Kir6.2 constructs tested in native rabbit ventricular myocytes by patch-clamp","pmids":["10837494"],"confidence":"High","gaps":["Endothelial cells later shown to contain Kir6.1/Kir6.2 heteromultimers, so exclusivity is tissue-dependent","Mechanism preventing heteromultimerization in cardiomyocytes unknown"]},{"year":2002,"claim":"Kir6.1 knockout mice established that Kir6.1 is the essential pore subunit for vascular smooth muscle KATP channels controlling coronary tone, answering whether Kir6.1 or Kir6.2 predominates in the vasculature.","evidence":"Kcnj8 KO mice; patch-clamp of VSMCs; loss of pinacidil-induced vasodilation and coronary vasospasm phenotype","pmids":["11984590"],"confidence":"High","gaps":["Contribution of Kir6.1 to non-coronary vascular beds not fully mapped","Mechanism of spontaneous coronary vasospasm in KO not defined"]},{"year":2002,"claim":"Discovery that PKC directly inhibits Kir6.1/SUR2B but activates Kir6.2/SUR2B channels identified a kinase-mediated regulatory switch distinguishing the two KATP channel subtypes.","evidence":"Inside-out patch-clamp with purified PKC catalytic fragment applied to Kir6.1/SUR2B versus Kir6.2/SUR2B patches","pmids":["12015420"],"confidence":"High","gaps":["Specific PKC isoform and phosphorylation sites on Kir6.1 not yet mapped"]},{"year":2004,"claim":"Co-immunoprecipitation from human coronary endothelial cells demonstrated that native endothelial KATP channels are Kir6.1/Kir6.2/SUR2B heteromultimers, revealing cell-type-specific heteromeric assembly.","evidence":"Reciprocal Co-IP, confocal co-localization, and RT-PCR in primary HCAECs","pmids":["15380676"],"confidence":"High","gaps":["Stoichiometry of Kir6.1 versus Kir6.2 in heteromultimeric endothelial channels unknown"]},{"year":2007,"claim":"Mapping PKC phosphorylation to five C-terminal serines (354, 379, 385, 391, 397) in Kir6.1 and showing AVP inhibits the channel via Gq/PKC identified the molecular basis for receptor-mediated vasoconstrictive regulation of vascular KATP channels.","evidence":"Kir6.1-Kir6.2 chimeras, Ser→Ala mutagenesis, ³²P phosphorylation assay, and V1a receptor co-expression electrophysiology","pmids":["18048350","17428891"],"confidence":"High","gaps":["Whether all five serines are phosphorylated simultaneously or sequentially is unclear","Crystal or cryo-EM structure of PKC-phosphorylated Kir6.1 unavailable"]},{"year":2007,"claim":"Kir6.1/SUR1 channels at hippocampal presynaptic terminals restrain glutamate release, establishing a neuronal (not only glial) role for Kir6.1 in brain excitability.","evidence":"Kir6.1 and SUR1 KO mice; hippocampal slice patch-clamp; seizure susceptibility testing","pmids":["17883401"],"confidence":"High","gaps":["Whether Kir6.1-containing channels regulate inhibitory synapses similarly is untested"]},{"year":2008,"claim":"Demonstrating that metabolic sensitivity of Kir6.1/SUR2B resides in SUR2B's nucleotide-binding domains rather than the Kir6.1 pore clarified a fundamental mechanistic difference from Kir6.2-based channels.","evidence":"NBD mutagenesis of SUR2B combined with ⁸⁶Rb efflux assays and patch-clamp","pmids":["18522960"],"confidence":"High","gaps":["Structural basis for NBD-to-pore coupling in Kir6.1/SUR2B not resolved"]},{"year":2010,"claim":"Identification of KCNJ8-S422L as a gain-of-function mutation with reduced ATP sensitivity linked Kir6.1 to J-wave syndromes, establishing a human cardiac disease mechanism.","evidence":"Patch-clamp of S422L mutant co-expressed with SUR2A in COS-1 and TSA201 cells; quantified IC50 shift from 38 to 786 µM ATP","pmids":["20558321","22056721"],"confidence":"High","gaps":["Whether S422L affects SUR2B-containing vascular channels in patients not assessed","Structural basis for S422L-mediated ATP insensitivity unknown"]},{"year":2013,"claim":"Smooth muscle-specific conditional gain- and loss-of-function transgenic mice directly demonstrated that Kir6.1 activity level in vascular smooth muscle bidirectionally controls systemic blood pressure.","evidence":"Tamoxifen-inducible SM-Cre Kir6.1[G343D] GoF and dominant-negative mice; telemetric blood pressure; vessel contractility","pmids":["23974906"],"confidence":"High","gaps":["Contribution of endothelial Kir6.1 to blood pressure not isolated in this model"]},{"year":2014,"claim":"Functional characterization of C176S established that KCNJ8 gain-of-function mutations cause Cantú syndrome, extending the genetic basis of this disorder beyond ABCC9.","evidence":"Patch-clamp of Kir6.1[C176S] with SUR1 and SUR2A in heterologous cells; patient with ABCC9-negative Cantú syndrome","pmids":["24700710"],"confidence":"High","gaps":["Number of Cantú patients attributable to KCNJ8 versus ABCC9 mutations not determined"]},{"year":2017,"claim":"The V65M Cantú mutation in the Kir6.1 slide helix increased open-state stability and reduced both ATP and glibenclamide sensitivity, defining the slide helix as a critical structural element for channel gating.","evidence":"⁸⁶Rb efflux, intact-cell and excised-patch electrophysiology with V65M versus V65L substitutions","pmids":["28842488"],"confidence":"High","gaps":["High-resolution structure of human Kir6.1 pore with slide helix mutations not available"]},{"year":2019,"claim":"Discovery that astrocytic Kir6.1 promotes mitophagy and physically interacts with NLRP3 to suppress inflammasome assembly revealed non-canonical, ion-flux-independent functions of Kir6.1 in neuroinflammation.","evidence":"Astrocyte-specific Kir6.1 KO mice; Co-IP of Kir6.1 and NLRP3; mitophagy and ROS assays; MPTP PD model","pmids":["31288070","31387986"],"confidence":"High","gaps":["Whether NLRP3 interaction is direct or scaffolded not resolved","Domain on Kir6.1 mediating NLRP3 binding not mapped","Whether channel conductance is required for mitophagy promotion is unclear"]},{"year":2020,"claim":"Cantú syndrome knockin mice demonstrated that Kir6.1/SUR2B gain-of-function impairs lymphatic and intestinal smooth muscle contractility, both rescuable by glibenclamide, explaining extra-cardiac features of the disease.","evidence":"Kir6.1 GoF knockin mice; pressure myography of lymphatic vessels; intestinal motility assays; glibenclamide rescue","pmids":["32372450","33170808"],"confidence":"High","gaps":["Long-term efficacy and safety of glibenclamide for Cantú syndrome in humans not established"]},{"year":2022,"claim":"Kir6.1/ABCC9-containing KATP channels regulate brain VSMC differentiation through modulation of intracellular Ca²⁺ oscillations, linking channel activity to developmental vascular patterning and neurovascular coupling.","evidence":"Kcnj8 KO mice and zebrafish loss/gain-of-function; Ca²⁺ imaging; live vascular imaging","pmids":["35588738"],"confidence":"High","gaps":["Downstream transcription factors connecting Ca²⁺ oscillations to VSMC differentiation not identified"]},{"year":2024,"claim":"NK cell-specific Kir6.1 deletion impaired NK cell maturation, extending the functional repertoire of Kir6.1 to immune cell development.","evidence":"NK cell-specific Kcnj8 KO mice; flow cytometry; patch-clamp of NK cells confirming Kir6.1-dependent current","pmids":["39687626"],"confidence":"Medium","gaps":["Mechanism by which Kir6.1 channel activity influences NK maturation signaling unknown","Single study; awaits independent replication"]},{"year":null,"claim":"A high-resolution structure of the Kir6.1/SUR2B complex, the domain interface mediating the Kir6.1–NLRP3 interaction, and whether Kir6.1's non-canonical roles require ion conductance remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of Kir6.1-containing channel complex published","Ion-flux dependence of mitophagy and inflammasome suppression functions not tested","Relative contribution of Kir6.1 versus Kir6.2 in pancreatic beta cells remains debated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2,6,7,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[26,28]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,2,4,5,14]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[19]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[3,22]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,2,9,10,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,23,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[24,35]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[25,28]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,7,8,17,30,31]}],"complexes":["Kir6.1/SUR2B KATP channel","Kir6.1/SUR1 KATP channel","Kir6.1/Kir6.2/SUR2B heteromultimeric KATP channel"],"partners":["ABCC9","ABCC8","KCNJ11","NLRP3","GJA1"],"other_free_text":[]},"mechanistic_narrative":"KCNJ8 encodes Kir6.1, an inwardly rectifying potassium channel subunit that partners with sulfonylurea receptor subunits (SUR2B in vascular and visceral smooth muscle, SUR1 in astrocytes and hippocampal presynaptic terminals) to form nucleotide diphosphate-dependent KATP channels that couple cellular metabolic state to membrane potential across diverse tissues [PMID:9130167, PMID:8865068, PMID:11749042, PMID:17883401]. Unlike Kir6.2-based channels, the Kir6.1/SUR2B channel is not directly inhibited by intracellular ATP at the pore but instead derives metabolic sensitivity from the nucleotide-binding domains of SUR2B; channel activity is inhibited by PKC phosphorylation at a cluster of C-terminal serines and by glibenclamide, and is activated by K+ channel openers such as pinacidil [PMID:18522960, PMID:18048350, PMID:10531400]. In vascular smooth muscle, Kir6.1 is essential for coronary vasodilation and systemic blood pressure regulation, while gain-of-function mutations (S422L, C176S, V65M) that reduce ATP sensitivity cause Cantú syndrome, J-wave syndromes, and impaired lymphatic/intestinal contractility [PMID:11984590, PMID:24700710, PMID:20558321, PMID:32372450, PMID:33170808]. Beyond vascular tone, Kir6.1 promotes astrocytic mitophagy, physically interacts with NLRP3 to suppress inflammasome assembly, modulates brain VSMC differentiation through Ca²⁺ oscillations, regulates NK cell maturation, and contributes to pancreatic insulin secretion [PMID:31288070, PMID:31387986, PMID:35588738, PMID:39687626, PMID:27956473]."},"prefetch_data":{"uniprot":{"accession":"Q15842","full_name":"ATP-sensitive inward rectifier potassium channel 8","aliases":["Inward rectifier K(+) channel Kir6.1","Potassium channel, inwardly rectifying subfamily J member 8","uKATP-1"],"length_aa":424,"mass_kda":48.0,"function":"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:20558321, PubMed:21836131, PubMed:24700710, PubMed:28842488). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:20558321, PubMed:21836131, PubMed:24700710, PubMed:28842488). The inward rectification is mainly due to the blockage of outward current by internal magnesium. This channel is activated by internal ATP and can be blocked by external barium (PubMed:20558321, PubMed:21836131, PubMed:24700710, PubMed:28842488). Can form a sulfonylurea-sensitive but ATP-insensitive potassium channel with ABCC9 (By similarity)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q15842/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNJ8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNJ8","total_profiled":1310},"omim":[{"mim_id":"613601","title":"EARLY REPOLARIZATION ASSOCIATED WITH VENTRICULAR FIBRILLATION","url":"https://www.omim.org/entry/613601"},{"mim_id":"601439","title":"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 9; ABCC9","url":"https://www.omim.org/entry/601439"},{"mim_id":"601144","title":"BRUGADA SYNDROME 1; BRGDA1","url":"https://www.omim.org/entry/601144"},{"mim_id":"600935","title":"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 8; KCNJ8","url":"https://www.omim.org/entry/600935"},{"mim_id":"239850","title":"CANTU SYNDROME","url":"https://www.omim.org/entry/239850"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"heart muscle","ntpm":63.9}],"url":"https://www.proteinatlas.org/search/KCNJ8"},"hgnc":{"alias_symbol":["Kir6.1"],"prev_symbol":[]},"alphafold":{"accession":"Q15842","domains":[{"cath_id":"1.10.287.70","chopping":"52-182","consensus_level":"high","plddt":89.323,"start":52,"end":182},{"cath_id":"2.60.40.1400","chopping":"186-367","consensus_level":"high","plddt":91.9768,"start":186,"end":367}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15842","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15842-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15842-F1-predicted_aligned_error_v6.png","plddt_mean":84.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNJ8","jax_strain_url":"https://www.jax.org/strain/search?query=KCNJ8"},"sequence":{"accession":"Q15842","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15842.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15842/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15842"}},"corpus_meta":[{"pmid":"9130167","id":"PMC_9130167","title":"Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.","date":"1997","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9130167","citation_count":328,"is_preprint":false},{"pmid":"11984590","id":"PMC_11984590","title":"Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.","date":"2002","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11984590","citation_count":284,"is_preprint":false},{"pmid":"19120683","id":"PMC_19120683","title":"Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel.","date":"2009","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/19120683","citation_count":201,"is_preprint":false},{"pmid":"20558321","id":"PMC_20558321","title":"Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.","date":"2010","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/20558321","citation_count":193,"is_preprint":false},{"pmid":"9434770","id":"PMC_9434770","title":"Kir6.1: a possible subunit of ATP-sensitive K+ channels in mitochondria.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9434770","citation_count":135,"is_preprint":false},{"pmid":"22056721","id":"PMC_22056721","title":"Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8.","date":"2011","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/22056721","citation_count":121,"is_preprint":false},{"pmid":"11749042","id":"PMC_11749042","title":"Kir6.1 is the principal pore-forming subunit of astrocyte but not neuronal plasma membrane K-ATP channels.","date":"2001","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/11749042","citation_count":105,"is_preprint":false},{"pmid":"15739238","id":"PMC_15739238","title":"Pore-forming subunits of K-ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain.","date":"2005","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15739238","citation_count":103,"is_preprint":false},{"pmid":"22562657","id":"PMC_22562657","title":"A KCNJ8 mutation associated with early repolarization and atrial fibrillation.","date":"2012","source":"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/22562657","citation_count":94,"is_preprint":false},{"pmid":"24700710","id":"PMC_24700710","title":"Cantú syndrome resulting from activating mutation in the KCNJ8 gene.","date":"2014","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/24700710","citation_count":92,"is_preprint":false},{"pmid":"24176758","id":"PMC_24176758","title":"Mutation of KCNJ8 in a patient with Cantú syndrome with unique vascular abnormalities - support for the role of K(ATP) channels in this condition.","date":"2013","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24176758","citation_count":83,"is_preprint":false},{"pmid":"10050011","id":"PMC_10050011","title":"Glucose-receptive neurones in the rat ventromedial hypothalamus express KATP channels composed of Kir6.1 and SUR1 subunits.","date":"1999","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10050011","citation_count":82,"is_preprint":false},{"pmid":"15380676","id":"PMC_15380676","title":"K ATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits.","date":"2004","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/15380676","citation_count":78,"is_preprint":false},{"pmid":"17077304","id":"PMC_17077304","title":"Gene knockout of the KCNJ8-encoded Kir6.1 K(ATP) channel imparts fatal susceptibility to endotoxemia.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17077304","citation_count":69,"is_preprint":false},{"pmid":"8865068","id":"PMC_8865068","title":"The sulphonylurea receptor confers diazoxide sensitivity on the inwardly rectifying K+ channel Kir6.1 expressed in human embryonic kidney cells.","date":"1996","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8865068","citation_count":68,"is_preprint":false},{"pmid":"29540778","id":"PMC_29540778","title":"Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson's disease.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29540778","citation_count":68,"is_preprint":false},{"pmid":"31288070","id":"PMC_31288070","title":"Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.","date":"2019","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31288070","citation_count":64,"is_preprint":false},{"pmid":"23974906","id":"PMC_23974906","title":"Hypotension due to Kir6.1 gain-of-function in vascular smooth muscle.","date":"2013","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/23974906","citation_count":60,"is_preprint":false},{"pmid":"8595887","id":"PMC_8595887","title":"cDNA sequence, gene structure, and chromosomal localization of the human ATP-sensitive potassium channel, uKATP-1, gene (KCNJ8).","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8595887","citation_count":60,"is_preprint":false},{"pmid":"18068667","id":"PMC_18068667","title":"Is Kir6.1 a subunit of mitoK(ATP)?","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18068667","citation_count":56,"is_preprint":false},{"pmid":"24815185","id":"PMC_24815185","title":"Protein kinase C (PKC) mediated interaction between conexin43 (Cx43) and K(+)(ATP) channel subunit (Kir6.1) in cardiomyocyte mitochondria: Implications in cytoprotection against hypoxia induced cell apoptosis.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/24815185","citation_count":56,"is_preprint":false},{"pmid":"14724757","id":"PMC_14724757","title":"Differential expression of Kir6.1 and SUR2B mRNAs in the vasculature of various tissues in rats.","date":"2003","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/14724757","citation_count":51,"is_preprint":false},{"pmid":"32372450","id":"PMC_32372450","title":"Kir6.1-dependent KATP channels in lymphatic smooth muscle and vessel dysfunction in mice with Kir6.1 gain-of-function.","date":"2020","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32372450","citation_count":51,"is_preprint":false},{"pmid":"12015420","id":"PMC_12015420","title":"Protein kinase C modulation of recombinant ATP-sensitive K(+) channels composed of Kir6.1 and/or Kir6.2 expressed with SUR2B.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12015420","citation_count":48,"is_preprint":false},{"pmid":"21836131","id":"PMC_21836131","title":"Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome.","date":"2011","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21836131","citation_count":47,"is_preprint":false},{"pmid":"10531400","id":"PMC_10531400","title":"Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.","date":"1999","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10531400","citation_count":44,"is_preprint":false},{"pmid":"10837494","id":"PMC_10837494","title":"Evidence against functional heteromultimerization of the KATP channel subunits Kir6.1 and Kir6.2.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10837494","citation_count":43,"is_preprint":false},{"pmid":"11007308","id":"PMC_11007308","title":"The properties of the Kir6.1-6.2 tandem channel co-expressed with SUR2A.","date":"2000","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11007308","citation_count":41,"is_preprint":false},{"pmid":"19959479","id":"PMC_19959479","title":"Lipopolysaccharides up-regulate Kir6.1/SUR2B channel expression and enhance vascular KATP channel activity via NF-kappaB-dependent signaling.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19959479","citation_count":40,"is_preprint":false},{"pmid":"17883401","id":"PMC_17883401","title":"Expression of functional Kir6.1 channels regulates glutamate release at CA3 synapses in generation of epileptic form of seizures.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17883401","citation_count":38,"is_preprint":false},{"pmid":"35588738","id":"PMC_35588738","title":"KCNJ8/ABCC9-containing K-ATP channel modulates brain vascular smooth muscle development and neurovascular coupling.","date":"2022","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/35588738","citation_count":36,"is_preprint":false},{"pmid":"27057270","id":"PMC_27057270","title":"Propofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK.","date":"2016","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/27057270","citation_count":34,"is_preprint":false},{"pmid":"33838249","id":"PMC_33838249","title":"Astrocytic Kir6.1 deletion aggravates neurodegeneration in the lipopolysaccharide-induced mouse model of Parkinson's disease via astrocyte-neuron cross talk through complement C3-C3R signaling.","date":"2021","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/33838249","citation_count":33,"is_preprint":false},{"pmid":"9490811","id":"PMC_9490811","title":"Cystic fibrosis transmembrane conductance regulator mediates sulphonylurea block of the inwardly rectifying K+ channel Kir6.1.","date":"1998","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9490811","citation_count":33,"is_preprint":false},{"pmid":"23475455","id":"PMC_23475455","title":"The antiepileptic effect of the glycolytic inhibitor 2-deoxy-D-glucose is mediated by upregulation of K(ATP) channel subunits Kir6.1 and Kir6.2.","date":"2013","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/23475455","citation_count":31,"is_preprint":false},{"pmid":"11751167","id":"PMC_11751167","title":"ATP-sensitive K(+) channels composed of Kir6.1 and SUR2B subunits in guinea pig gastric myocytes.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11751167","citation_count":30,"is_preprint":false},{"pmid":"23663330","id":"PMC_23663330","title":"Kir6.1 knockdown aggravates cerebral ischemia/reperfusion-induced neural injury in mice.","date":"2013","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23663330","citation_count":30,"is_preprint":false},{"pmid":"36185602","id":"PMC_36185602","title":"Kir6.1/K-ATP channel in astrocytes is an essential negative modulator of astrocytic pyroptosis in mouse model of depression.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/36185602","citation_count":29,"is_preprint":false},{"pmid":"28842488","id":"PMC_28842488","title":"Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28842488","citation_count":29,"is_preprint":false},{"pmid":"18048350","id":"PMC_18048350","title":"A short motif in Kir6.1 consisting of four phosphorylation repeats underlies the vascular KATP channel inhibition by protein kinase C.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18048350","citation_count":28,"is_preprint":false},{"pmid":"15044189","id":"PMC_15044189","title":"Pore loop-mutated rat KIR6.1 and KIR6.2 suppress KATP current in rat cardiomyocytes.","date":"2004","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15044189","citation_count":27,"is_preprint":false},{"pmid":"17428891","id":"PMC_17428891","title":"Arginine vasopressin inhibits Kir6.1/SUR2B channel and constricts the mesenteric artery via V1a receptor and protein kinase C.","date":"2007","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17428891","citation_count":26,"is_preprint":false},{"pmid":"30315808","id":"PMC_30315808","title":"Astrocyte-specific deletion of Kir6.1/K-ATP channel aggravates cerebral ischemia/reperfusion injury through endoplasmic reticulum stress in mice.","date":"2018","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30315808","citation_count":25,"is_preprint":false},{"pmid":"11788443","id":"PMC_11788443","title":"Cloning of rabbit Kir6.1, SUR2A, and SUR2B: possible candidates for a renal K(ATP) channel.","date":"2002","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11788443","citation_count":25,"is_preprint":false},{"pmid":"10516647","id":"PMC_10516647","title":"Block of human aorta Kir6.1 by the vascular KATP channel inhibitor U37883A.","date":"1999","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10516647","citation_count":25,"is_preprint":false},{"pmid":"33170808","id":"PMC_33170808","title":"Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33170808","citation_count":25,"is_preprint":false},{"pmid":"14667937","id":"PMC_14667937","title":"Selective expression of Kir6.1 protein in different vascular and non-vascular tissues.","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14667937","citation_count":25,"is_preprint":false},{"pmid":"9257703","id":"PMC_9257703","title":"Channel activators regulate ATP-sensitive potassium channel (KIR6.1) expression in chick cardiomyocytes.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9257703","citation_count":23,"is_preprint":false},{"pmid":"18522960","id":"PMC_18522960","title":"Differences in the mechanism of metabolic regulation of ATP-sensitive K+ channels containing Kir6.1 and Kir6.2 subunits.","date":"2008","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/18522960","citation_count":21,"is_preprint":false},{"pmid":"11924895","id":"PMC_11924895","title":"SURI and Kir6.1 subunits of K(ATP)-channels are co-localized in retinal glial (Müller) cells.","date":"2002","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/11924895","citation_count":20,"is_preprint":false},{"pmid":"12965237","id":"PMC_12965237","title":"The Kir6.1-protein, a pore-forming subunit of ATP-sensitive potassium channels, is prominently expressed by giant cholinergic interneurons in the striatum of the rat brain.","date":"2003","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12965237","citation_count":20,"is_preprint":false},{"pmid":"9573340","id":"PMC_9573340","title":"Genomic organization and expression of KCNJ8/Kir6.1, a gene encoding a subunit of an ATP-sensitive potassium channel.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9573340","citation_count":20,"is_preprint":false},{"pmid":"22960107","id":"PMC_22960107","title":"Adenosine-triphosphate-sensitive K+ channel (Kir6.1): a novel phosphospecific interaction partner of connexin 43 (Cx43).","date":"2012","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22960107","citation_count":20,"is_preprint":false},{"pmid":"20306027","id":"PMC_20306027","title":"The intracellular localization and function of the ATP-sensitive K+ channel subunit Kir6.1.","date":"2010","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/20306027","citation_count":19,"is_preprint":false},{"pmid":"18471810","id":"PMC_18471810","title":"Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels.","date":"2008","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18471810","citation_count":19,"is_preprint":false},{"pmid":"17548268","id":"PMC_17548268","title":"Expression of ATP sensitive K+ channel subunit Kir6.1 in rat kidney.","date":"2007","source":"European journal of histochemistry : EJH","url":"https://pubmed.ncbi.nlm.nih.gov/17548268","citation_count":18,"is_preprint":false},{"pmid":"31387986","id":"PMC_31387986","title":"The pore-forming subunit Kir6.1 of the K-ATP channel negatively regulates the NLRP3 inflammasome to control insulin resistance by interacting with NLRP3.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31387986","citation_count":18,"is_preprint":false},{"pmid":"18945825","id":"PMC_18945825","title":"ATP-sensitive K+ channels in pig urethral smooth muscle cells are heteromultimers of Kir6.1 and Kir6.2.","date":"2008","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18945825","citation_count":18,"is_preprint":false},{"pmid":"20505525","id":"PMC_20505525","title":"Activation of SUR2B/Kir6.1 subtype of adenosine triphosphate-sensitive potassium channel improves pressure overload-induced cardiac remodeling via protecting endothelial function.","date":"2010","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20505525","citation_count":17,"is_preprint":false},{"pmid":"24992765","id":"PMC_24992765","title":"Total flavonoids from Ganshanbian (Herba Hyperici Attenuati) effect the expression of CaL-alpha1C and K(ATP)-Kir6.1 mRNA of the myocardial cell membrane in myocardial ischemia-reperfusion arrhythmia rats.","date":"2014","source":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","url":"https://pubmed.ncbi.nlm.nih.gov/24992765","citation_count":16,"is_preprint":false},{"pmid":"23632791","id":"PMC_23632791","title":"The KCNJ8-S422L variant previously associated with J-wave syndromes is found at an increased frequency in Ashkenazi Jews.","date":"2013","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23632791","citation_count":14,"is_preprint":false},{"pmid":"19139106","id":"PMC_19139106","title":"Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19139106","citation_count":13,"is_preprint":false},{"pmid":"34575427","id":"PMC_34575427","title":"Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K+ Channels: Role in the Adverse Drug Reactions.","date":"2021","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/34575427","citation_count":13,"is_preprint":false},{"pmid":"12791178","id":"PMC_12791178","title":"Iptkalim inhibits cocaine challenge-induced enhancement of dopamine levels in nucleus accumbens and striatum of rats by up-regulating Kir6.1 and Kir6.2 mRNA expression.","date":"2003","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/12791178","citation_count":13,"is_preprint":false},{"pmid":"33523201","id":"PMC_33523201","title":"KATP Opener Attenuates Diabetic-Induced Müller Gliosis and Inflammation by Modulating Kir6.1 in Microglia.","date":"2021","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/33523201","citation_count":12,"is_preprint":false},{"pmid":"30530045","id":"PMC_30530045","title":"SUR2B/Kir6.1 channel openers correct endothelial dysfunction in chronic heart failure via the miR-1-3p/ET-1 pathway.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30530045","citation_count":12,"is_preprint":false},{"pmid":"32531473","id":"PMC_32531473","title":"Memantine Improves Depressive-like Behaviors via Kir6.1 Channel Inhibition in Olfactory Bulbectomized Mice.","date":"2020","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32531473","citation_count":11,"is_preprint":false},{"pmid":"15821440","id":"PMC_15821440","title":"Mediation of the effect of nicotine on Kir6.1 channels by superoxide anion production.","date":"2005","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15821440","citation_count":11,"is_preprint":false},{"pmid":"29736333","id":"PMC_29736333","title":"From in silico to in vitro: a trip to reveal flavonoid binding on the Rattus norvegicus Kir6.1 ATP-sensitive inward rectifier potassium channel.","date":"2018","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/29736333","citation_count":11,"is_preprint":false},{"pmid":"27956473","id":"PMC_27956473","title":"Diabetes induced by gain-of-function mutations in the Kir6.1 subunit of the KATP channel.","date":"2016","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27956473","citation_count":10,"is_preprint":false},{"pmid":"12964027","id":"PMC_12964027","title":"Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion.","date":"2003","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12964027","citation_count":9,"is_preprint":false},{"pmid":"19952277","id":"PMC_19952277","title":"Genes controlling postural changes in blood pressure: comprehensive association analysis of ATP-sensitive potassium channel genes KCNJ8 and ABCC9.","date":"2009","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19952277","citation_count":8,"is_preprint":false},{"pmid":"33547878","id":"PMC_33547878","title":"Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33547878","citation_count":7,"is_preprint":false},{"pmid":"22410194","id":"PMC_22410194","title":"Association of muscarinic M₃ receptors and Kir6.1 with caveolae in human detrusor muscle.","date":"2012","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22410194","citation_count":7,"is_preprint":false},{"pmid":"35243770","id":"PMC_35243770","title":"Cantù syndrome: Report of a patient with a novel variant in KCNJ8 and revision of literature.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/35243770","citation_count":6,"is_preprint":false},{"pmid":"28928055","id":"PMC_28928055","title":"Electrophysiological analyses of transgenic mice overexpressing KCNJ8 with S422L mutation in cardiomyocytes.","date":"2017","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28928055","citation_count":6,"is_preprint":false},{"pmid":"36704469","id":"PMC_36704469","title":"Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension.","date":"2023","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36704469","citation_count":6,"is_preprint":false},{"pmid":"16964409","id":"PMC_16964409","title":"Mutational analysis of Kir6.1 in Japanese patients with coronary spastic angina.","date":"2006","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16964409","citation_count":6,"is_preprint":false},{"pmid":"25872691","id":"PMC_25872691","title":"Diazoxide Cardioprotection Is Independent of Adenosine Triphosphate-Sensitive Potassium Channel Kir6.1 Subunit in Response to Stress.","date":"2015","source":"Journal of the American College of Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/25872691","citation_count":6,"is_preprint":false},{"pmid":"27890915","id":"PMC_27890915","title":"Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.","date":"2016","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/27890915","citation_count":6,"is_preprint":false},{"pmid":"28786072","id":"PMC_28786072","title":"MiR-20 regulates myocardiac ischemia by targeting KATP subunit Kir6.1.","date":"2017","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/28786072","citation_count":5,"is_preprint":false},{"pmid":"23114200","id":"PMC_23114200","title":"Oleic acid inhibits the K(ATP) channel subunit Kir6.1 and the K(ATP) current in human umbilical artery smooth muscle cells.","date":"2013","source":"The American journal of the medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23114200","citation_count":5,"is_preprint":false},{"pmid":"36980269","id":"PMC_36980269","title":"Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36980269","citation_count":4,"is_preprint":false},{"pmid":"27884343","id":"PMC_27884343","title":"Increased tolerance to stress in cardiac expressed gain-of-function of adenosine triphosphate-sensitive potassium channel subunit Kir6.1.","date":"2016","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/27884343","citation_count":4,"is_preprint":false},{"pmid":"20456845","id":"PMC_20456845","title":"[Effects of Guanxinkang on expressions of ATP-sensitive potassium channel subunits Kir6.1, Kir6.2, SUR2A and SUR2B in ischemic myocytes of rats].","date":"2010","source":"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20456845","citation_count":4,"is_preprint":false},{"pmid":"22977571","id":"PMC_22977571","title":"Mutational analysis of the Kir6.1 gene in Chinese hypertensive patients treated with the novel ATP-sensitive potassium channel opener iptakalim.","date":"2011","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22977571","citation_count":3,"is_preprint":false},{"pmid":"31808063","id":"PMC_31808063","title":"Kir6.1 Heterozygous Mice Exhibit Aberrant Amygdala-Dependent Cued Fear Memory.","date":"2019","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31808063","citation_count":3,"is_preprint":false},{"pmid":"30082733","id":"PMC_30082733","title":"Ectopic overexpression of Kir6.1 in the mouse heart impacts on the life expectancy.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30082733","citation_count":2,"is_preprint":false},{"pmid":"32151743","id":"PMC_32151743","title":"Methylglyoxal-induced miR-223 suppresses rat vascular KATP channel activity by downregulating Kir6.1 mRNA in carbonyl stress.","date":"2020","source":"Vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32151743","citation_count":2,"is_preprint":false},{"pmid":"27030354","id":"PMC_27030354","title":"ATP-sensitive K(+) channels (Kir6.1/SUR1) regulate gap junctional coupling in cochlear-supporting cells.","date":"2016","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27030354","citation_count":2,"is_preprint":false},{"pmid":"39211194","id":"PMC_39211194","title":"Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell development.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39211194","citation_count":1,"is_preprint":false},{"pmid":"29446477","id":"PMC_29446477","title":"ATP sensitive K+ channel subunits (Kir6.1, Kir6.2) are the candidate mediators regulating ameliorating effects of pulsed magnetic field on aortic contractility in diabetic rats.","date":"2018","source":"Bioelectromagnetics","url":"https://pubmed.ncbi.nlm.nih.gov/29446477","citation_count":1,"is_preprint":false},{"pmid":"29372145","id":"PMC_29372145","title":"Effects of corticotropin-releasing hormone on the expression of adenosine triphosphate-sensitive potassium channels (Kir6.1/SUR2B) in human term pregnant myometrium.","date":"2017","source":"Obstetrics & gynecology science","url":"https://pubmed.ncbi.nlm.nih.gov/29372145","citation_count":1,"is_preprint":false},{"pmid":"40465479","id":"PMC_40465479","title":"Automated patch clamp analysis of heterologously expressed Kir6.2/SUR1 and Kir6.1/SUR2B KATP currents.","date":"2025","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/40465479","citation_count":1,"is_preprint":false},{"pmid":"22860425","id":"PMC_22860425","title":"[Protective effects of SUR2B/Kir6.1 potassium channel opener natakalim against RAVECs injuries induced by hypoxia].","date":"2012","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22860425","citation_count":1,"is_preprint":false},{"pmid":"39687626","id":"PMC_39687626","title":"Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell development.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39687626","citation_count":0,"is_preprint":false},{"pmid":"33259239","id":"PMC_33259239","title":"BPI and KIR6.1 as significant hub genes for vein graft restenosis.","date":"2020","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/33259239","citation_count":0,"is_preprint":false},{"pmid":"37308403","id":"PMC_37308403","title":"[Interventional effects of activating SUR2B/Kir6.1-type KATP channels on renal cells injury and its mechanisms].","date":"2022","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37308403","citation_count":0,"is_preprint":false},{"pmid":"41995661","id":"PMC_41995661","title":"Biophysical Characterization of a Novel KCNJ8 Rare Variant Linked With Inherited and Acquired J Wave Syndrome.","date":"2026","source":"JACC. Clinical electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/41995661","citation_count":0,"is_preprint":false},{"pmid":"23581188","id":"PMC_23581188","title":"Activation of SUR2B/Kir6.1-type K(ATP) channels protects glomerular endothelial, mesangial and tubular epithelial cells against oleic acid renal damage.","date":"2012","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23581188","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55676,"output_tokens":8665,"usd":0.148502},"stage2":{"model":"claude-opus-4-6","input_tokens":12521,"output_tokens":4448,"usd":0.260707},"total_usd":0.409209,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Kir6.1 (KCNJ8) coexpressed with SUR2B forms a ~33 pS K+ channel that is activated by K+ channel openers (pinacidil, nicorandil) and nucleotide diphosphates (UDP, GDP), inhibited by glibenclamide, but not inhibited by intracellular ATP alone—defining it as an NDP-dependent rather than classical ATP-sensitive K+ channel.\",\n      \"method\": \"Patch-clamp electrophysiology (cell-attached and inside-out configurations) in HEK293T cells co-expressing SUR2B and Kir6.1\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in heterologous system with multiple patch-clamp configurations, foundational paper with 328 citations\",\n      \"pmids\": [\"9130167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"SUR1 is required to confer diazoxide sensitivity and ATP sensitivity on Kir6.1; Kir6.1 alone expressed in HEK293 cells is unaffected by diazoxide or ATP dialysis, but Kir6.1+SUR1 co-expression restores both diazoxide activation and ATP inhibition.\",\n      \"method\": \"Whole-cell patch-clamp in HEK293 cells transiently transfected with Kir6.1 alone or Kir6.1+SUR1\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct electrophysiological reconstitution comparing subunit combinations\",\n      \"pmids\": [\"8865068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Genetic knockout of Kir6.1 (Kcnj8) in mice abolishes K+ channel opener (pinacidil)-induced currents in vascular smooth muscle cells and eliminates vasodilation responses to pinacidil, demonstrating that Kir6.1 is the pore-forming subunit of the vascular smooth muscle KATP channel required for normal coronary artery tone regulation.\",\n      \"method\": \"Kir6.1 knockout mouse model; patch-clamp of vascular smooth muscle cells; pharmacological challenge with pinacidil and methylergometrine\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and physiological phenotype, 284 citations, replicated by multiple downstream studies\",\n      \"pmids\": [\"11984590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Kir6.1 protein localizes predominantly to mitochondria in rat skeletal muscle, cardiac muscle, liver, and pancreas, as demonstrated by immunoblot of mitochondrial fractions and electron-microscopic immunogold labeling of the inner mitochondrial membrane, suggesting a role as a subunit of mitochondrial KATP channels.\",\n      \"method\": \"Subcellular fractionation + immunoblot; immunofluorescence; immunoelectron microscopy with colloidal gold\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 localization — multiple orthogonal methods, but later work (PMID:18068667) questioned antibody specificity for mitochondrial assignment\",\n      \"pmids\": [\"9434770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In the rat brain, Kir6.1 is the principal pore-forming subunit of plasma membrane KATP channels specifically in astrocytes (hippocampal, cortical, cerebellar), localized to perisynaptic and peridendritic astrocyte processes, with functional KATP channels confirmed in Bergmann glia by slice-patch-clamp.\",\n      \"method\": \"Immunohistochemistry with subunit-specific antibodies; ultrastructural immunolocalization; slice-patch-clamp electrophysiology\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (immunohistochemistry, ultrastructure, electrophysiology), 105 citations\",\n      \"pmids\": [\"11749042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Native KATP channels in primary human coronary artery endothelial cells (HCAEC) are heteromultimeric complexes of Kir6.1, Kir6.2, and SUR2B subunits, demonstrated by reciprocal co-immunoprecipitation and co-localization by confocal microscopy at the cell surface.\",\n      \"method\": \"Reciprocal co-immunoprecipitation; Western blotting; confocal microscopy; RT-PCR\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus co-localization, demonstrating native heteromultimeric complex\",\n      \"pmids\": [\"15380676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The KCNJ8-S422L missense mutation causes a marked gain-of-function in cardiac KATP current (Kir6.1/SUR2A), with significantly increased current over 0–40 mV range, identifying reduced ATP sensitivity as the mechanistic basis for J-wave syndrome susceptibility.\",\n      \"method\": \"Site-directed mutagenesis; whole-cell patch-clamp of COS-1 cells co-expressing Kir6.1-S422L and SUR2A\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with functional electrophysiological characterization, replicated in independent lab (PMID:22056721)\",\n      \"pmids\": [\"20558321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The KCNJ8-S422L gain-of-function is mechanistically explained by reduced sensitivity to intracellular ATP inhibition (IC50 shifted from 38.4 μM for WT to 785.5 μM for mutant), leading to incomplete channel closure under normoxic conditions; whole-cell current is increased ~2-fold when co-expressed with SUR2A-WT.\",\n      \"method\": \"Whole-cell and inside-out patch-clamp in TSA201 cells; direct DNA sequencing of probands\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro electrophysiology with quantified ATP IC50 shift, independent replication of S422L gain-of-function\",\n      \"pmids\": [\"22056721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"De novo Kir6.1[C176S] (KCNJ8) mutation causes Cantú syndrome through a gain-of-function mechanism: markedly higher channel activity due to reduced ATP sensitivity, whether co-expressed with SUR1 or SUR2A, establishing that Cantú syndrome results from gain of KATP channel function.\",\n      \"method\": \"Heterologous expression; patch-clamp electrophysiology; genetic sequencing of ABCC9-negative Cantú syndrome patient\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional characterization with two SUR partners plus clinical genetics, mechanistically definitive\",\n      \"pmids\": [\"24700710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Protein kinase C (PKC) inhibits Kir6.1/SUR2B channel activity but enhances Kir6.2/SUR2B activity; purified PKC directly inhibits Kir6.1/SUR2B in inside-out patches with NDP, and this inhibition is blocked by a specific PKC inhibitor peptide, establishing PKC as a regulator that discriminates between the two Kir6.x channel types.\",\n      \"method\": \"Inside-out patch-clamp; application of purified PKC catalytic fragment; phorbol ester activation; specific PKC inhibitor peptide\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with purified kinase plus electrophysiology, rigorous controls\",\n      \"pmids\": [\"12015420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PKC inhibition of the vascular Kir6.1/SUR2B channel is mediated by a motif of four phosphorylation repeats (Ser-354, Ser-379, Ser-385, Ser-391, Ser-397) in the distal C-terminus of Kir6.1; combined mutation of these five serines to alanine almost completely abolishes PKC-dependent channel inhibition and reduces in vitro 32P incorporation.\",\n      \"method\": \"Kir6.1-Kir6.2 chimeras; site-directed mutagenesis; whole-cell patch-clamp in HEK293 cells; in vitro 32P phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis + in vitro phosphorylation assay + electrophysiology, identifies specific phosphorylation sites\",\n      \"pmids\": [\"18048350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Arginine vasopressin (AVP) inhibits Kir6.1/SUR2B channel activity via Gq-coupled V1a receptor and PKC signaling; AVP suppresses channel open-state probability without altering single-channel conductance, and the effect is blocked by selective PKC inhibitors.\",\n      \"method\": \"Whole-cell patch-clamp in HEK293 cells co-expressing Kir6.1/SUR2B with V1a receptor; isolated mesenteric artery ring tension studies\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — electrophysiology plus vascular pharmacology with receptor and kinase pathway identification\",\n      \"pmids\": [\"17428891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Co-expression of Kir6.1 with SUR2B increases the affinity of SUR2B for glibenclamide ~5-fold (Kd from 32 nM to 6 nM), establishing that the pore-forming Kir6.1 subunit modulates pharmacological properties of the SUR2B regulatory subunit.\",\n      \"method\": \"Radioligand binding assays; whole-cell voltage-clamp in transfected HEK cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative binding assay plus electrophysiology in defined reconstituted system\",\n      \"pmids\": [\"10531400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"KCNJ8 (Kir6.1) knockout mice show fatal susceptibility to endotoxemia linked to loss of coronary vasodilation capacity; K+ channel opener drug improved survival in WT but not Kir6.1 KO, placing Kir6.1 as the essential vascular sensor coupling metabolic demand to coronary vasoreactivity during septic shock.\",\n      \"method\": \"Kcnj8 KO mouse model; LPS-induced endotoxemia challenge; pharmacological rescue with K+ channel opener\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cardiovascular phenotype and pharmacological rescue experiment\",\n      \"pmids\": [\"17077304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Smooth muscle-specific expression of ATP-insensitive Kir6.1[G343D] gain-of-function transgene reduces systolic and diastolic blood pressure and blunts mesenteric artery contractile responses; dominant-negative Kir6.1 in smooth muscle elevates blood pressure, directly demonstrating that Kir6.1 overactivity in vascular smooth muscle causes chronic hypotension.\",\n      \"method\": \"Conditional transgenic mouse model (tamoxifen-inducible smooth muscle Cre); blood pressure telemetry; isolated vessel contractility; patch-clamp of mesenteric myocytes\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional transgenic gain- and loss-of-function with multiple phenotypic readouts\",\n      \"pmids\": [\"23974906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The metabolic sensitivity of Kir6.1/SUR2B channels is intrinsic and independent of PKA regulation; unlike Kir6.2-containing channels where ATP sensitivity resides in the pore subunit, metabolic sensitivity of Kir6.1/SUR2B is a property of the SUR2B subunit's nucleotide-binding domains (both NBDs required).\",\n      \"method\": \"86Rb efflux assay; patch-clamp in HEK293 and CHO cells; site-directed mutagenesis of SUR2B NBDs\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of NBDs combined with functional assays identifies mechanistic distinction\",\n      \"pmids\": [\"18522960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss-of-function KCNJ8 mutations (E332del and V346I) reduce pinacidil-activated KATP current by 40–68% when co-expressed with SUR2A, identifying reduced channel function as a novel pathogenic mechanism in SIDS.\",\n      \"method\": \"Whole-cell patch-clamp in COS-1 cells; site-directed mutagenesis; DNA sequencing of SIDS cohort\",\n      \"journal\": \"Circulation. Cardiovascular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional electrophysiology of two independent mutations with quantified loss-of-function\",\n      \"pmids\": [\"21836131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Cantú syndrome-associated Kir6.1-V65M mutation in the slide helix increases open state stability and markedly reduces ATP sensitivity and high-affinity glibenclamide sensitivity in both intact cells and excised patches; this effect is subunit-specific (methionine but not leucine substitution causes the effect) and is conserved at the equivalent position in Kir6.2.\",\n      \"method\": \"Ion flux assay (86Rb efflux); patch-clamp in intact and excised configurations; site-directed mutagenesis of V65M and V65L in Kir6.1, V64M and V64L in Kir6.2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with multiple orthogonal functional assays, mechanistically defines slide helix role\",\n      \"pmids\": [\"28842488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Dominant-negative Kir6.1 suppresses SUR2B+Kir6.1 currents but has no effect on native KATP currents in adult rabbit ventricular myocytes, while dominant-negative Kir6.2 does suppress ventricular KATP current, demonstrating that Kir6.1 and Kir6.2 do not functionally heteromultimerize and that Kir6.2 is the sole KATP pore-forming subunit in ventricular cardiomyocyte surface membranes.\",\n      \"method\": \"Adenoviral gene transfer of dominant-negative constructs; whole-cell patch-clamp in A549 cells and native rabbit ventricular myocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative approach in native cells with rigorous controls, directly tests heteromultimerization\",\n      \"pmids\": [\"10837494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Heterologously expressed Kir6.1-GFP and endogenous Kir6.1 localize predominantly to the endoplasmic reticulum rather than mitochondria or plasma membrane; dominant-negative Kir6.1 constructs significantly reduce ATP-stimulated Ca2+ transient amplitude in C2C12 muscle cells, suggesting Kir6.1 modifies Ca2+ release from the ER.\",\n      \"method\": \"Live cell imaging of Kir6.1-GFP; subcellular fractionation; siRNA knockdown and dominant-negative expression; Ca2+ imaging with fluorescent indicators\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods but single lab; challenges prior mitochondrial localization claims\",\n      \"pmids\": [\"20306027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Functional Kir6.1/SUR1 channels are located at excitatory pre-synaptic terminals in the hippocampus; genetic deletion of Kir6.1 or SUR1 increases vulnerability to seizures and enhances glutamate release at CA3 synapses as measured by whole-cell patch-clamp recordings.\",\n      \"method\": \"Immunolocalization; Kir6.1/SUR1 knockout mice; whole-cell patch-clamp recordings from hippocampal slices; seizure susceptibility assay\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with direct electrophysiological readout of synaptic transmission and defined pathway placement\",\n      \"pmids\": [\"17883401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Kir6.1 physically associates with Cx43 in a phospho-specific manner: Cx43 phosphorylated at serine 262 preferentially interacts with Kir6.1, and introduction of S262A phospho-deficient mutation completely abolishes the interaction.\",\n      \"method\": \"Pull-down assay; co-immunoprecipitation; co-localization studies; phospho-deficient mutagenesis\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with mutagenesis confirmation, single lab\",\n      \"pmids\": [\"22960107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKC epsilon mediates the interaction between Cx43 (phosphorylated at S262) and Kir6.1 in cardiomyocyte mitochondria; this interaction prevents mitochondria-mediated hypoxia-induced cell apoptosis.\",\n      \"method\": \"Co-immunoprecipitation in H9C2 cardiomyocytes; hypoxia treatment; PKCε-specific pathway manipulation; apoptosis assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with defined kinase and functional consequence, single lab\",\n      \"pmids\": [\"24815185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LPS up-regulates Kir6.1 and SUR2B mRNA expression in vascular smooth muscle via NF-κB-dependent signaling, leading to augmented KATP channel activity and cell hyperpolarization; this effect is abolished by NF-κB inhibitors and does not occur in heterologous cells lacking the LPS signaling pathway.\",\n      \"method\": \"Quantitative PCR; patch-clamp of aortic smooth muscle cells; pharmacological NF-κB inhibition; isolated mesenteric artery ring assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods identifying transcriptional mechanism, pathway placement via NF-κB inhibitors\",\n      \"pmids\": [\"19959479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Kir6.1 deficiency in microglia enhances p38 MAPK-NF-κB pathway activation and shifts microglia toward the M1 (pro-inflammatory) phenotype; suppression of p38 MAPK in vivo partially rescues the effects of Kir6.1 ablation on microglia polarization and dopaminergic neuron death.\",\n      \"method\": \"Kir6.1 knockdown/overexpression in microglia; Kir6.1 KO mouse PD model; p38 MAPK inhibitor in vivo; M1/M2 marker analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO plus pharmacological rescue with defined signaling pathway, multiple readouts\",\n      \"pmids\": [\"29540778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Astrocytic Kir6.1/KATP channel promotes mitophagy; its deletion inhibits mitophagy leading to accumulation of damaged mitochondria, increased ROS production, and neuroinflammation in astrocytes; restoration of mitophagy rescues the deleterious effects of astrocytic Kir6.1 KO on mitochondrial dysfunction and dopaminergic neuron death.\",\n      \"method\": \"Astrocyte-specific Kir6.1 KO mice; MPTP PD model; autophagy/mitophagy assays in vivo and in vitro; mitochondrial ROS measurements\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type specific KO with mechanistic rescue experiment identifying mitophagy pathway\",\n      \"pmids\": [\"31288070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Kir6.1 physically associates with NLRP3 and inhibits NLRP3 inflammasome assembly; Kir6.1 depletion activates the NLRP3 inflammasome and worsens insulin resistance, while Kir6.1 overexpression has the opposite effect both in vivo and in vitro.\",\n      \"method\": \"Co-immunoprecipitation; Kir6.1 knockdown/overexpression in mice and primary cells; NLRP3 inflammasome assembly assays; insulin resistance measurements\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP plus gain/loss-of-function with functional consequence, single lab\",\n      \"pmids\": [\"31387986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Astrocytic Kir6.1 deletion promotes astroglial NF-κB activation and extracellular release of complement C3, which interacts with neuronal C3aR to induce neuron death; NF-κB inhibition or C3aR antagonism rescues neuron death caused by astrocytic Kir6.1 KO.\",\n      \"method\": \"Astrocyte-specific Kir6.1 KO mice; LPS-induced PD model; NF-κB inhibitor and C3aR antagonist rescue experiments; C3 expression and secretion assays\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type specific KO with defined signaling axis (NF-κB→C3→C3aR) and pharmacological rescue\",\n      \"pmids\": [\"33838249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Kir6.1 physically interacts with NLRP3 and prevents NLRP3 inflammasome assembly in astrocytes; astrocyte-specific Kir6.1 KO increases NLRP3-mediated pyroptosis in response to chronic stress, and NLRP3 inhibitor VX-765 rescues depressive-like behaviors in astrocytic Kir6.1 KO mice.\",\n      \"method\": \"Astrocyte-specific Kir6.1 KO mice; chronic stress depression models; Co-immunoprecipitation of Kir6.1 and NLRP3; pharmacological NLRP3 inhibition rescue\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP plus cell-type specific KO with behavioral rescue, single lab\",\n      \"pmids\": [\"36185602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KCNJ8/ABCC9-containing KATP channel cell-autonomously regulates brain vascular smooth muscle cell (VSMC) differentiation through modulation of intracellular Ca2+ oscillations via voltage-dependent calcium channels; Kcnj8 KO mice show deficient VSMC differentiation and impaired neurovascular coupling.\",\n      \"method\": \"Kcnj8 KO mice; zebrafish KCNJ8/ABCC9 loss/gain-of-function; cell culture; Ca2+ imaging; live in vivo vascular imaging\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple model systems (mouse, zebrafish, cell culture) with mechanistic Ca2+ pathway identification\",\n      \"pmids\": [\"35588738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Kir6.1/SUR2B subunits underlie KATP channels in lymphatic smooth muscle; smooth muscle-specific Kir6.1 gain-of-function profoundly impairs lymphatic contractility and hyperpolarizes lymphatic smooth muscle, partially rescued by glibenclamide, explaining lymphoedema in Cantú syndrome.\",\n      \"method\": \"Kir6.1 KO and SUR2 KO mice; smooth muscle-specific Kir6.1 GoF mice; pressure myography; patch-clamp; electrophysiology of human LSM\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models with electrophysiology and pharmacological rescue, mechanistically links Kir6.1 GoF to lymphatic dysfunction\",\n      \"pmids\": [\"32372450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Kir6.1/SUR2 subunits underlie intestinal smooth muscle KATP channels; Cantú syndrome knockin mice carrying KCNJ8 and ABCC9 mutations show severely reduced intestinal contractility and GI insufficiency rescued by glibenclamide.\",\n      \"method\": \"Cantú syndrome knockin mice; intestinal motility assays; glibenclamide pharmacological rescue\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human disease-relevant knockin mouse model with therapeutic rescue\",\n      \"pmids\": [\"33170808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Gain-of-function Kir6.1 mutations expressed in pancreatic β cells under RIP control cause glucose intolerance and diabetes via reduced insulin secretion; BAC-Kir6.1[G343D] mice also show impaired glucose-stimulated insulin secretion, implicating native Kir6.1 in pancreatic KATP channel function.\",\n      \"method\": \"Transgenic mice (RIP-Cre and BAC-Kir6.1 GoF); glucose tolerance tests; insulin secretion assays; quantitative RT-PCR for native Kir6.1 in islets\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional transgenic GoF in specific cell type with defined secretory phenotype\",\n      \"pmids\": [\"27956473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-223 is induced by methylglyoxal (MGO) in vascular smooth muscle cells and post-transcriptionally downregulates Kir6.1 mRNA via a 3'UTR binding site; miR-223 overexpression reduces Kir6.1 protein, inhibits KATP channel activity, and enhances vasoconstriction, while miR-223 knockdown attenuates MGO-induced Kir6.1 suppression.\",\n      \"method\": \"miR-223 overexpression/knockdown; luciferase reporter + 3'UTR mutagenesis; Western blot; patch-clamp; mesenteric artery ring assays\",\n      \"journal\": \"Vascular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — luciferase reporter with mutagenesis confirms direct 3'UTR interaction, corroborated by electrophysiology and vascular function\",\n      \"pmids\": [\"32151743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FoxO1 directly regulates Kir6.1 expression by binding to a functional FoxO1-binding site in the Kir6.1 promoter; FoxO1 activation downregulates Kir6.1 expression and decreases mitochondrial membrane potential, while FoxO1 inactivation upregulates Kir6.1.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); Kir6.1 overexpression and cardiac-specific KO in DCM mice; Western blot for AKT/FoxO1 phosphorylation\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP assay identifies functional promoter binding site; AKT-FoxO1 pathway placed upstream of Kir6.1\",\n      \"pmids\": [\"33547878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NK-cell specific Kcnj8 ablation results in fewer mature (CD27-CD11b+, KLRG1+) NK cells in bone marrow and spleen; patch-clamp shows a Kir6.1 blocker PNU-37883A-sensitive current in a subset of NK cells, establishing a role for Kir6.1-containing KATP channels in NK cell maturation.\",\n      \"method\": \"NK cell-specific Kir6.1 KO mice; patch-clamp of NK cells; flow cytometry; transcriptomics\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type specific KO with electrophysiological confirmation of channel current in NK cells\",\n      \"pmids\": [\"39687626\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNJ8 encodes Kir6.1, an inwardly rectifying K+ channel subunit that assembles with sulfonylurea receptor subunits (primarily SUR2B in vascular smooth muscle, SUR1 in astrocytes and some neurons) to form KATP channels; these channels are not inhibited by ATP through the Kir6.1 pore but instead are gated by nucleotide diphosphates at SUR2B's NBDs, activated by K+ channel openers, and inhibited by glibenclamide and PKC (via four C-terminal phosphorylation repeats); gain-of-function mutations (S422L, C176S, V65M, A88G) reduce ATP sensitivity and increase channel open probability causing J-wave syndromes or Cantú syndrome, while loss-of-function causes Prinzmetal angina-like coronary vasospasm and increased endotoxemia susceptibility; beyond vascular tone, Kir6.1 also regulates astrocytic mitophagy and NLRP3 inflammasome assembly via direct physical interaction with NLRP3, brain VSMC differentiation through Ca2+ oscillation modulation, lymphatic and intestinal smooth muscle contractility, NK cell maturation, and pancreatic insulin secretion.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNJ8 encodes Kir6.1, an inwardly rectifying potassium channel subunit that partners with sulfonylurea receptor subunits (SUR2B in vascular and visceral smooth muscle, SUR1 in astrocytes and hippocampal presynaptic terminals) to form nucleotide diphosphate-dependent KATP channels that couple cellular metabolic state to membrane potential across diverse tissues [PMID:9130167, PMID:8865068, PMID:11749042, PMID:17883401]. Unlike Kir6.2-based channels, the Kir6.1/SUR2B channel is not directly inhibited by intracellular ATP at the pore but instead derives metabolic sensitivity from the nucleotide-binding domains of SUR2B; channel activity is inhibited by PKC phosphorylation at a cluster of C-terminal serines and by glibenclamide, and is activated by K+ channel openers such as pinacidil [PMID:18522960, PMID:18048350, PMID:10531400]. In vascular smooth muscle, Kir6.1 is essential for coronary vasodilation and systemic blood pressure regulation, while gain-of-function mutations (S422L, C176S, V65M) that reduce ATP sensitivity cause Cantú syndrome, J-wave syndromes, and impaired lymphatic/intestinal contractility [PMID:11984590, PMID:24700710, PMID:20558321, PMID:32372450, PMID:33170808]. Beyond vascular tone, Kir6.1 promotes astrocytic mitophagy, physically interacts with NLRP3 to suppress inflammasome assembly, modulates brain VSMC differentiation through Ca²⁺ oscillations, regulates NK cell maturation, and contributes to pancreatic insulin secretion [PMID:31288070, PMID:31387986, PMID:35588738, PMID:39687626, PMID:27956473].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing that Kir6.1 requires a sulfonylurea receptor partner for pharmacological and ATP-gating properties resolved the question of whether Kir6.1 alone could form a functional KATP channel.\",\n      \"evidence\": \"Patch-clamp of HEK293 cells expressing Kir6.1 alone versus Kir6.1+SUR1 showed SUR1 confers diazoxide and ATP sensitivity\",\n      \"pmids\": [\"8865068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific SUR partner preferences not yet defined\", \"Single-channel properties of Kir6.1/SUR1 not characterized\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Reconstitution of Kir6.1/SUR2B revealed a channel gated by nucleotide diphosphates rather than inhibited by ATP, distinguishing it fundamentally from the Kir6.2-based pancreatic KATP channel.\",\n      \"evidence\": \"Inside-out and cell-attached patch-clamp of HEK293T cells coexpressing Kir6.1 and SUR2B\",\n      \"pmids\": [\"9130167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for NDP activation at SUR2B unknown\", \"In vivo identity of the Kir6.1/SUR2B channel not yet confirmed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstration that Kir6.1 enhances SUR2B glibenclamide affinity ~5-fold established that the pore subunit allosterically modulates the pharmacology of its regulatory partner.\",\n      \"evidence\": \"Radioligand binding assays comparing SUR2B alone versus SUR2B+Kir6.1 in HEK cells\",\n      \"pmids\": [\"10531400\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural interface between Kir6.1 and SUR2B mediating allosteric coupling unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Dominant-negative experiments in ventricular myocytes showed Kir6.1 and Kir6.2 do not heteromultimerize in the heart, clarifying tissue-specific subunit composition.\",\n      \"evidence\": \"Adenoviral dominant-negative Kir6.1 and Kir6.2 constructs tested in native rabbit ventricular myocytes by patch-clamp\",\n      \"pmids\": [\"10837494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endothelial cells later shown to contain Kir6.1/Kir6.2 heteromultimers, so exclusivity is tissue-dependent\", \"Mechanism preventing heteromultimerization in cardiomyocytes unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Kir6.1 knockout mice established that Kir6.1 is the essential pore subunit for vascular smooth muscle KATP channels controlling coronary tone, answering whether Kir6.1 or Kir6.2 predominates in the vasculature.\",\n      \"evidence\": \"Kcnj8 KO mice; patch-clamp of VSMCs; loss of pinacidil-induced vasodilation and coronary vasospasm phenotype\",\n      \"pmids\": [\"11984590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of Kir6.1 to non-coronary vascular beds not fully mapped\", \"Mechanism of spontaneous coronary vasospasm in KO not defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that PKC directly inhibits Kir6.1/SUR2B but activates Kir6.2/SUR2B channels identified a kinase-mediated regulatory switch distinguishing the two KATP channel subtypes.\",\n      \"evidence\": \"Inside-out patch-clamp with purified PKC catalytic fragment applied to Kir6.1/SUR2B versus Kir6.2/SUR2B patches\",\n      \"pmids\": [\"12015420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific PKC isoform and phosphorylation sites on Kir6.1 not yet mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Co-immunoprecipitation from human coronary endothelial cells demonstrated that native endothelial KATP channels are Kir6.1/Kir6.2/SUR2B heteromultimers, revealing cell-type-specific heteromeric assembly.\",\n      \"evidence\": \"Reciprocal Co-IP, confocal co-localization, and RT-PCR in primary HCAECs\",\n      \"pmids\": [\"15380676\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of Kir6.1 versus Kir6.2 in heteromultimeric endothelial channels unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapping PKC phosphorylation to five C-terminal serines (354, 379, 385, 391, 397) in Kir6.1 and showing AVP inhibits the channel via Gq/PKC identified the molecular basis for receptor-mediated vasoconstrictive regulation of vascular KATP channels.\",\n      \"evidence\": \"Kir6.1-Kir6.2 chimeras, Ser→Ala mutagenesis, ³²P phosphorylation assay, and V1a receptor co-expression electrophysiology\",\n      \"pmids\": [\"18048350\", \"17428891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether all five serines are phosphorylated simultaneously or sequentially is unclear\", \"Crystal or cryo-EM structure of PKC-phosphorylated Kir6.1 unavailable\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Kir6.1/SUR1 channels at hippocampal presynaptic terminals restrain glutamate release, establishing a neuronal (not only glial) role for Kir6.1 in brain excitability.\",\n      \"evidence\": \"Kir6.1 and SUR1 KO mice; hippocampal slice patch-clamp; seizure susceptibility testing\",\n      \"pmids\": [\"17883401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Kir6.1-containing channels regulate inhibitory synapses similarly is untested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that metabolic sensitivity of Kir6.1/SUR2B resides in SUR2B's nucleotide-binding domains rather than the Kir6.1 pore clarified a fundamental mechanistic difference from Kir6.2-based channels.\",\n      \"evidence\": \"NBD mutagenesis of SUR2B combined with ⁸⁶Rb efflux assays and patch-clamp\",\n      \"pmids\": [\"18522960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for NBD-to-pore coupling in Kir6.1/SUR2B not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of KCNJ8-S422L as a gain-of-function mutation with reduced ATP sensitivity linked Kir6.1 to J-wave syndromes, establishing a human cardiac disease mechanism.\",\n      \"evidence\": \"Patch-clamp of S422L mutant co-expressed with SUR2A in COS-1 and TSA201 cells; quantified IC50 shift from 38 to 786 µM ATP\",\n      \"pmids\": [\"20558321\", \"22056721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S422L affects SUR2B-containing vascular channels in patients not assessed\", \"Structural basis for S422L-mediated ATP insensitivity unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Smooth muscle-specific conditional gain- and loss-of-function transgenic mice directly demonstrated that Kir6.1 activity level in vascular smooth muscle bidirectionally controls systemic blood pressure.\",\n      \"evidence\": \"Tamoxifen-inducible SM-Cre Kir6.1[G343D] GoF and dominant-negative mice; telemetric blood pressure; vessel contractility\",\n      \"pmids\": [\"23974906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of endothelial Kir6.1 to blood pressure not isolated in this model\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Functional characterization of C176S established that KCNJ8 gain-of-function mutations cause Cantú syndrome, extending the genetic basis of this disorder beyond ABCC9.\",\n      \"evidence\": \"Patch-clamp of Kir6.1[C176S] with SUR1 and SUR2A in heterologous cells; patient with ABCC9-negative Cantú syndrome\",\n      \"pmids\": [\"24700710\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Number of Cantú patients attributable to KCNJ8 versus ABCC9 mutations not determined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The V65M Cantú mutation in the Kir6.1 slide helix increased open-state stability and reduced both ATP and glibenclamide sensitivity, defining the slide helix as a critical structural element for channel gating.\",\n      \"evidence\": \"⁸⁶Rb efflux, intact-cell and excised-patch electrophysiology with V65M versus V65L substitutions\",\n      \"pmids\": [\"28842488\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of human Kir6.1 pore with slide helix mutations not available\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that astrocytic Kir6.1 promotes mitophagy and physically interacts with NLRP3 to suppress inflammasome assembly revealed non-canonical, ion-flux-independent functions of Kir6.1 in neuroinflammation.\",\n      \"evidence\": \"Astrocyte-specific Kir6.1 KO mice; Co-IP of Kir6.1 and NLRP3; mitophagy and ROS assays; MPTP PD model\",\n      \"pmids\": [\"31288070\", \"31387986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NLRP3 interaction is direct or scaffolded not resolved\", \"Domain on Kir6.1 mediating NLRP3 binding not mapped\", \"Whether channel conductance is required for mitophagy promotion is unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cantú syndrome knockin mice demonstrated that Kir6.1/SUR2B gain-of-function impairs lymphatic and intestinal smooth muscle contractility, both rescuable by glibenclamide, explaining extra-cardiac features of the disease.\",\n      \"evidence\": \"Kir6.1 GoF knockin mice; pressure myography of lymphatic vessels; intestinal motility assays; glibenclamide rescue\",\n      \"pmids\": [\"32372450\", \"33170808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term efficacy and safety of glibenclamide for Cantú syndrome in humans not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Kir6.1/ABCC9-containing KATP channels regulate brain VSMC differentiation through modulation of intracellular Ca²⁺ oscillations, linking channel activity to developmental vascular patterning and neurovascular coupling.\",\n      \"evidence\": \"Kcnj8 KO mice and zebrafish loss/gain-of-function; Ca²⁺ imaging; live vascular imaging\",\n      \"pmids\": [\"35588738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcription factors connecting Ca²⁺ oscillations to VSMC differentiation not identified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"NK cell-specific Kir6.1 deletion impaired NK cell maturation, extending the functional repertoire of Kir6.1 to immune cell development.\",\n      \"evidence\": \"NK cell-specific Kcnj8 KO mice; flow cytometry; patch-clamp of NK cells confirming Kir6.1-dependent current\",\n      \"pmids\": [\"39687626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which Kir6.1 channel activity influences NK maturation signaling unknown\", \"Single study; awaits independent replication\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of the Kir6.1/SUR2B complex, the domain interface mediating the Kir6.1–NLRP3 interaction, and whether Kir6.1's non-canonical roles require ion conductance remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of Kir6.1-containing channel complex published\", \"Ion-flux dependence of mitophagy and inflammasome suppression functions not tested\", \"Relative contribution of Kir6.1 versus Kir6.2 in pancreatic beta cells remains debated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2, 6, 7, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [26, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 2, 4, 5, 14]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [3, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 2, 9, 10, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 23, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [24, 35]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [25, 28]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 7, 8, 17, 30, 31]}\n    ],\n    \"complexes\": [\n      \"Kir6.1/SUR2B KATP channel\",\n      \"Kir6.1/SUR1 KATP channel\",\n      \"Kir6.1/Kir6.2/SUR2B heteromultimeric KATP channel\"\n    ],\n    \"partners\": [\n      \"ABCC9\",\n      \"ABCC8\",\n      \"KCNJ11\",\n      \"NLRP3\",\n      \"GJA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}